-
Symbol
-
LIMN on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $ 0.0001 per share
-
Latest Disclosed Shares Owned
-
6,900,000 shares
-
Security Ownership %
-
26%
Iris Acquisition Holdings LLC ownership in Liminatus Pharma, Inc. Common Stock, par value $ 0.0001 per share (LIMN)
08 May 2025 - Iris Acquisition Holdings LLC has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,900,000 shares of Liminatus Pharma, Inc. Common Stock, par value $ 0.0001 per share (LIMN).
This represents 26% ownership of the company.
This is the first filing by Iris Acquisition Holdings LLC disclosing ownership of Liminatus Pharma, Inc. Common Stock, par value $ 0.0001 per share (LIMN).